Creatine - Metabolism
Research News and Information

Monday, November 23, 2009

A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men.

22 Sep 2009 BACKGROUND: Osteoprotegerin (OPG) has been associated with cardiovascular events but currently the mechanisms underlying this association are unknown. OPG is thought to play a role in controlling artery calcification and small studies have suggested ... Read more...

Effects of overnight sleep restriction on brain chemistry and mood in women with unipolar depression and healthy controls.

30 Aug 2009 BACKGROUND: Partial or total overnight sleep deprivation produces immediate mood improvement in about 50% of patients with depression, but not in healthy controls. Our objectives were to compare the neurochemical changes that accompanied partial ... Read more...

(1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques.

30 Aug 2009 PURPOSE: To investigate the signal-to-noise-ratio (SNR) and data quality of time-reduced three-dimensional (3D) proton magnetic resonance spectroscopic imaging ((1)H MRSI) techniques in the human brain at 3 Tesla. MATERIALS AND METHODS: Techniques ... Read more...

Latest indexed articles for 'Creatine - Metabolism'

These are the very latest articles for this heading:

• A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men. 22 Sep 2009
• Effects of overnight sleep restriction on brain chemistry and mood in women with unipolar depression and healthy controls. 30 Aug 2009
• (1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques. 30 Aug 2009
• Epilepsy spectrum in cerebral creatine transporter deficiency. 30 Aug 2009
• Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression. 11 Aug 2009
• Control of respiration in flight muscle from the high-altitude bar-headed goose and low-altitude birds. 3 Aug 2009
• Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMA-simulated basis sets at 4 Tesla. 30 Jul 2009
• Measurement of glutathione in normal volunteers and stroke patients at 3T using J-difference spectroscopy with minimized subtraction errors. 30 Jul 2009
• Circulating endothelial progenitor cells and age-related white matter changes. 21 Jul 2009
• MRI- and MRS-derived hippocampal correlates of quantitative locomotor function in older adults. 21 Jul 2009
• Use of short echo time two-dimensional 1H-magnetic resonance spectroscopy in temporal lobe epilepsy with negative magnetic resonance imaging findings. 29 Jun 2009
• Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse. 29 Jun 2009
• Diabetic striatal disease: clinical presentation, neuroimaging, and pathology. 29 Jun 2009
• Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias. 29 Jun 2009
• MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia. 28 Jun 2009
• Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study. 22 Jun 2009
• In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. 20 Jun 2009
• Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder. 13 Jun 2009
• Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression. 30 May 2009
• Alcohol abuse and acute behavioural disturbances in a 24-year-old patient. Diagnosis: Marchiafava-Bignami disease (MBD). 30 May 2009

See a longer list of these articles.

Technical information about 'Creatine'

Definition: An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine.

Chemical name: Glycine, N-(aminoiminomethyl)-N-methyl-

Registry Number: 57-00-1

Descriptor UI: D003401

Alternative terms: Creatine;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D02.078.370.280; D12.125.373;

Online Note: use CREATINE to search CREATINE AND CREATININE 1966-67

History Note: 68; CREATINE AND CREATININE was heading 1963-67

Technical Notes: do not confuse with CREATININE; CREATINE PHOSPHATE see PHOSPHOCREATINE